Literature DB >> 7197545

Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with chronic lung disease.

M E Miller, J F Garcia, R A Cohen, E P Cronkite, G Moccia, J Acevedo.   

Abstract

Serum levels of immunoreactive erythropoietin (Ep) were measured in 48 normal male and female volunteers, ages 20-60 years, to establish a control value for Ep of 18.5 +/- 5.0 (mean +/- SD) mU/ml. Levels of the hormone were also measured sequentially over a 24 h period of time in an additional 17 'normal' volunteers with no diurnal variation. Diurnal levels of immunoreactive Ep were also measured in 30 subjects, with chronic lung disease. These patients, in contrast to normal subjects exhibited a diurnal variation in the level of immunoreactive Ep with peak levels occurring at midnight. The only variable measured which correlated with the serum immunoreactive Ep level in subjects with chronic lung disease was the level of carboxyhaemoglobin (P less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197545     DOI: 10.1111/j.1365-2141.1981.tb07215.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

Review 1.  Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors:  Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Serum erythropoietin and blood lead concentrations.

Authors:  R Romeo; C Aprea; P Boccalon; D Orsi; B Porcelli; P Sartorelli
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Lack of sex dependence of the serum level of immunoreactive erythropoietin in chronic anemia.

Authors:  W Jelkmann; G Wiedemann
Journal:  Klin Wochenschr       Date:  1989-12-04

4.  Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.

Authors:  A Gaudard; E Varlet-Marie; M Audran; R Gomeni; F Bressolle
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

5.  Does obstructive sleep apnea increase hematocrit?

Authors:  Jong Bae Choi; José S Loredo; Daniel Norman; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

6.  Modulation of erythropoietin formation by changes in blood volume in conscious dogs.

Authors:  H Ehmke; A Just; K U Eckardt; P B Persson; C Bauer; H R Kirchheim
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

Review 7.  Oxygen transport in chronic hypoxic lung disease.

Authors:  D C Flenley
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

8.  Diurnal variations of serum erythropoietin at sea level and altitude.

Authors:  T Klausen; T D Poulsen; N Fogh-Andersen; J P Richalet; O J Nielsen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  Erythropoietin concentrations in obstructive sleep apnoea.

Authors:  J M Goldman; R M Ireland; M Berthon-Jones; R R Grunstein; C E Sullivan; J C Biggs
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

10.  Diurnal variations of serum erythropoietin in trained and untrained subjects.

Authors:  T Klausen; F Dela; E Hippe; H Galbo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.